Cowen And Company, LLC United Therapeutics Corp Transaction History

Cowen And Company, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$214.88 - $256.94 $2.01 Million - $2.4 Million	9,342 New	9,342 $2.05 Million
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $1.8 Million - $2.11 Million	-9,780 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$179.86 - $214.88 $1.76 Million - $2.1 Million	9,780 New	9,780 $1.81 Million
Q1 2020 May 11, 2020	SELL	$79.39 - $115.35 $1.41 Million - $2.05 Million	-17,742 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$78.31 - $95.34 $1.39 Million - $1.69 Million	17,742 New	17,742 $1.56 Million

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.